WO2005033333A3 - Methodes et compositions pour le diagnostic de cancer - Google Patents

Methodes et compositions pour le diagnostic de cancer Download PDF

Info

Publication number
WO2005033333A3
WO2005033333A3 PCT/DK2004/000670 DK2004000670W WO2005033333A3 WO 2005033333 A3 WO2005033333 A3 WO 2005033333A3 DK 2004000670 W DK2004000670 W DK 2004000670W WO 2005033333 A3 WO2005033333 A3 WO 2005033333A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
diagnosis
compositions
methods
fragments
Prior art date
Application number
PCT/DK2004/000670
Other languages
English (en)
Other versions
WO2005033333A2 (fr
Inventor
Miu Fun Chau
Kirsten Bisgaard-Franzen
Jone Lin
Ole Feldballe Rasmussen
Zunde Wang
Jason Lusk
Martin Lindberg
Sienna Yoast
Original Assignee
Dako Denmark As
Miu Fun Chau
Kirsten Bisgaard-Franzen
Jone Lin
Ole Feldballe Rasmussen
Zunde Wang
Jason Lusk
Martin Lindberg
Sienna Yoast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dako Denmark As, Miu Fun Chau, Kirsten Bisgaard-Franzen, Jone Lin, Ole Feldballe Rasmussen, Zunde Wang, Jason Lusk, Martin Lindberg, Sienna Yoast filed Critical Dako Denmark As
Publication of WO2005033333A2 publication Critical patent/WO2005033333A2/fr
Publication of WO2005033333A3 publication Critical patent/WO2005033333A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Dans un mode de réalisation, la présente invention concerne une méthode de détection d'un cancer du col de l'utérus et d'autres types de cancer, au moyen d'un mélange d'au moins trois clones génomiques ou de fragments correspondants, du papillomavirus humain à risque élevé. Par exemple, cette invention a trait à une composition contenant au moins trois clones génomiques de pleine longueur ou des fragments associés des papillomavirus humains à risque élevé.
PCT/DK2004/000670 2003-10-07 2004-10-04 Methodes et compositions pour le diagnostic de cancer WO2005033333A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US50920503P 2003-10-07 2003-10-07
DKPA200301474 2003-10-07
DKPA200301474 2003-10-07
US60/509,205 2003-10-07
US54392504P 2004-02-13 2004-02-13
US60/543,925 2004-02-13

Publications (2)

Publication Number Publication Date
WO2005033333A2 WO2005033333A2 (fr) 2005-04-14
WO2005033333A3 true WO2005033333A3 (fr) 2005-07-07

Family

ID=34426534

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2004/000670 WO2005033333A2 (fr) 2003-10-07 2004-10-04 Methodes et compositions pour le diagnostic de cancer

Country Status (2)

Country Link
US (2) US8221970B2 (fr)
WO (1) WO2005033333A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
ATE474066T1 (de) 2005-11-15 2010-07-15 Genoid Kft Verfahren zum nachweis von pathogenen mittels molecular beacons
AU2006341730B2 (en) * 2006-04-11 2013-04-11 Bio-Rad Innovations HPV detection and quantification by real-time multiplex amplification
US20100003704A1 (en) 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
US8916342B2 (en) * 2006-11-13 2014-12-23 Oncohealth Corp. Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
AU2007342569A1 (en) * 2006-12-19 2008-07-17 Albert Einstein College Of Medicine Of Yeshiva University Radioimmunotherapy and imaging of tumor cells that express viral antigens
GB0701818D0 (en) * 2007-01-31 2007-03-14 Univ Manchester Prognostic marker for cancer
CN101730847B (zh) * 2007-04-05 2015-03-18 分类生物系统有限公司 组合物及检测方法
JP5302519B2 (ja) * 2007-08-03 2013-10-02 倉敷紡績株式会社 ヒトパピローマウイルスを検出するためのプライマーセット及びプローブ
US20090259112A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Sensors
US20090259217A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems associated with delivery of one or more agents to an individual
ES2668555T3 (es) 2008-05-27 2018-05-18 Dako Denmark A/S Composiciones y métodos para la detección de aberraciones cromosómicas con tampones de hibridación novedosos
KR101018407B1 (ko) 2008-06-13 2011-03-02 엠앤디 (주) 인유두종 바이러스 진단용 프로브 및 그 유전자형 확인방법
US8288520B2 (en) 2008-10-27 2012-10-16 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and system
CA2653478A1 (fr) * 2009-01-23 2010-07-23 Gregg Martin Lave-vehicules industriels
US9050287B2 (en) * 2009-01-23 2015-06-09 The Trustees Of The University Of Pennsylvania Vaccines for human papilloma virus and methods for using the same
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
EP2521914A4 (fr) 2010-01-08 2013-07-10 Oncohealth Corp Immunoessais sur le vph à base de cellule et à haut débit pour diagnostiquer et dépister des cancers associés au vph
US8781184B2 (en) * 2010-02-10 2014-07-15 Tokitae Llc Systems, devices, and methods for detection of malaria
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
EP2761028A1 (fr) * 2011-09-30 2014-08-06 Dako Denmark A/S Compositions d'hybridation et procédés utilisant du formamide
WO2013144344A2 (fr) * 2012-03-30 2013-10-03 Istituto Europeo Di Oncologia S.R.L. Biomarqueurs pour des infections par le pvh, méthodes et kits de diagnostic associés
EP3586870A1 (fr) 2013-03-12 2020-01-01 The Trustees Of The University Of Pennsylvania Vaccins améliorés pour le papillomavirus humain et leurs procédés d'utilisation
CA2961613A1 (fr) 2014-09-17 2016-03-24 Hologic, Inc. Procede de lyse partielle et dosage
JP7044554B2 (ja) * 2015-05-10 2022-03-30 ヴェンタナ メディカル システムズ， インク． 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法
EP3115766A1 (fr) 2015-07-10 2017-01-11 3Scan Inc. Multiplexage spatial de colorations histologiques
CN110093459A (zh) * 2019-06-05 2019-08-06 中国人民解放军总医院第五医学中心 用于快速检测13种高危型hpv的lamp引物组合及应用
CN111089964B (zh) * 2019-12-26 2022-04-12 江苏美克医学技术有限公司 一种用于宫颈癌辅助诊断的免疫荧光双染试剂盒
CN116380602B (zh) * 2023-06-05 2023-09-08 深圳市森盈生物科技有限公司 一种液基细胞学和免疫细胞化学双制片染色试剂盒及应用

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
EP0524807A1 (fr) * 1991-07-22 1993-01-27 Cerveceria Polar, Ca Procédé et réactifs pour la détection du papillomavirus humaine
WO1993004197A1 (fr) * 1991-08-13 1993-03-04 Universitaire Instelling Antwerpen Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique
WO2001011361A2 (fr) * 1999-08-04 2001-02-15 Dako A/S Trousse diagnostique et son utilisation
US6218104B1 (en) * 1987-02-26 2001-04-17 Biosearch International Pty. Ltd. Method of detection of carcinogenic human papillomavirus
WO2001037192A1 (fr) * 1999-11-18 2001-05-25 Ikonisys, Inc. Procede et appareil, commandes par ordinateur, pour le diagnostic en fonction d'une cellule
WO2001068915A1 (fr) * 2000-03-15 2001-09-20 Biomedlab Corporation Kit de genotypage utilise pour diagnostiquer une infection par le papillomavirus humain
EP1201771A2 (fr) * 1997-09-16 2002-05-02 Innogenetics N.V. Détection et identification du papillomavirus humain par PCR et d' hybridation inréversé specifique de type
WO2002061139A2 (fr) * 2001-01-29 2002-08-08 Ventana Medical Systems, Inc. Tampons d'hybridation au moyen de dextran-sulfate a faible poids moleculaire et leurs methodes d'utilisation
EP1302550A1 (fr) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Procédé et détecteur pour la détection de virus de type de HPV
WO2003057914A2 (fr) * 2002-01-07 2003-07-17 Norchip A/S Methode permettant de detecter l'arn messager du papillomavirus humain
WO2003062803A2 (fr) * 2002-01-24 2003-07-31 Tripath Imaging, Inc. Procede de video-microscopie quantitative et systeme associe, et produit de programme logiciel informatique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02501442A (ja) * 1987-10-02 1990-05-24 マイクロプローブ・コーポレーシヨン ヌクレオチドプローブによるヒト乳頭腫の型の診断
US4886741A (en) 1987-12-09 1989-12-12 Microprobe Corporation Use of volume exclusion agents for the enhancement of in situ hybridization
US5750340A (en) 1995-04-07 1998-05-12 University Of New Mexico In situ hybridization solution and process
EP1030934A4 (fr) * 1997-11-10 2004-03-17 Univ California Methodes biochimiques de detection d'une dysplasie et d'un cancer du col
ATE370251T1 (de) 1998-10-26 2007-09-15 Ventana Med Syst Inc Nachweis des humanen papilloma-virus mit hilfe des papanicolau-tests
EP1294939B1 (fr) 2000-04-03 2010-01-27 Cytyc Corporation Detection et typage du papillomavirus humain a l'aide de sondes de proteines pna

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US6218104B1 (en) * 1987-02-26 2001-04-17 Biosearch International Pty. Ltd. Method of detection of carcinogenic human papillomavirus
EP0524807A1 (fr) * 1991-07-22 1993-01-27 Cerveceria Polar, Ca Procédé et réactifs pour la détection du papillomavirus humaine
WO1993004197A1 (fr) * 1991-08-13 1993-03-04 Universitaire Instelling Antwerpen Procede pour detecter un virus dans la substance cellulaire d'un prelevement ou d'un liquide organique
EP1201771A2 (fr) * 1997-09-16 2002-05-02 Innogenetics N.V. Détection et identification du papillomavirus humain par PCR et d' hybridation inréversé specifique de type
WO2001011361A2 (fr) * 1999-08-04 2001-02-15 Dako A/S Trousse diagnostique et son utilisation
WO2001037192A1 (fr) * 1999-11-18 2001-05-25 Ikonisys, Inc. Procede et appareil, commandes par ordinateur, pour le diagnostic en fonction d'une cellule
WO2001068915A1 (fr) * 2000-03-15 2001-09-20 Biomedlab Corporation Kit de genotypage utilise pour diagnostiquer une infection par le papillomavirus humain
WO2002061139A2 (fr) * 2001-01-29 2002-08-08 Ventana Medical Systems, Inc. Tampons d'hybridation au moyen de dextran-sulfate a faible poids moleculaire et leurs methodes d'utilisation
EP1302550A1 (fr) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Procédé et détecteur pour la détection de virus de type de HPV
WO2003057914A2 (fr) * 2002-01-07 2003-07-17 Norchip A/S Methode permettant de detecter l'arn messager du papillomavirus humain
WO2003062803A2 (fr) * 2002-01-24 2003-07-31 Tripath Imaging, Inc. Procede de video-microscopie quantitative et systeme associe, et produit de programme logiciel informatique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GIARNIERI E ET AL: "Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. SEP 2000, vol. 6, no. 9, September 2000 (2000-09-01), pages 3600 - 3606, XP002327822, ISSN: 1078-0432 *
SHERMAN MARK E ET AL: "Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.", JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1 JAN 2003, vol. 95, no. 1, 1 January 2003 (2003-01-01), pages 46 - 52, XP002316502, ISSN: 0027-8874 *

Also Published As

Publication number Publication date
US8221970B2 (en) 2012-07-17
WO2005033333A2 (fr) 2005-04-14
US8513398B2 (en) 2013-08-20
US20060160069A1 (en) 2006-07-20
US20120259105A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
WO2005033333A3 (fr) Methodes et compositions pour le diagnostic de cancer
PL1797281T3 (pl) Sposób oceny geometrii szczeliny, stosowane w nim kompozycje i wyroby
WO2007030810A3 (fr) Moniteur de sang total multiparametrique et procede associe
WO2006015035A8 (fr) Composés utiles pour l'infection par hpv
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
WO2005058835A3 (fr) Procedes de preparation de formes cristallines d'aripiprazole
HUP0401935A3 (en) Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
HUS1500060I1 (hu) A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
WO2003045230A3 (fr) Compositions et procedes contre le cancer
WO2005051313A3 (fr) Procedes et reactifs pour le traitement, la prevention et le diagnostic d'infection par le bunyavirus
IL181691A0 (en) Method for the preparation of 2'-deoxy-2',2'-difluorocytidine
WO2003057146A3 (fr) Compositions et procedes concernant le cancer
IL179138A0 (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31,45, or 52
EP1670894B8 (fr) Compositions comprenant divers types de facteur de transfert, procedes de preparation des compositions et methodes de traitement mettant en oeuvre les compositions
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
WO2004030631A3 (fr) Compositions anticancereuses et contre les maladies infectieuses, et procedes d'utilisation correspondants
AP2006003530A0 (en) Immunogenic HIV compositions and related methods.
AU2003255611A1 (en) Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
ZA200601001B (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same
WO2003035837A3 (fr) Nouvelles compositions et procedes relatifs au cancer
EP2088197A3 (fr) Antigènes de Haemophilus influenzae et fragments d'ADN correspondants
WO2003022224A3 (fr) Fonction de la cyclo-oxygenase 2 et guerison des blessures
EP1689400A4 (fr) Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement
WO2004078142A3 (fr) Compositions et methodes de preventions et de traitement de maladies et d'etats pathologiques associes aux endotoxines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WR Later publication of a revised version of an international search report
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase